Sign inJoin free

Watch / Small Cap

Genetic Signatures

14 Apr 202218:09

Genetic Signatures

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Dr John Melki Genetic Signatures (GSS) CEO joins the program to answer questions raised by our expert guests on 'the call.' He explains how COVID allowed the company to prove up its medical technology, continue its expansion into Europe and the US, and sell more equipment. Listen for John's plans to further grow the business. Genetic Signatures is a specialist molecular diagnostics (MDx) company focused on the development and commercialisation of its proprietary platform technology, 3base™. Genetic Signatures has released a suite of real-time PCR based products for the routine detection of infectious diseases under the EasyScreen™ brand . This proprietary MDx technology provides hospitals and pathology laboratories with the ability to screen for a wide array of infectious pathogens with a high degree of specificity in a rapid throughput (time to result) environment. Genetic Signatures’ executive management team combines the scientific skills of the technology developers with the business acumen of industry veterans experienced in critical expansion markets.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy